BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25667282)

  • 1. Reply to s. Chakraborty et al.
    Cohen EE; Kocherginsky M; Karrison T; Seiwert TY; Haraf DJ; Brockstein B; Vokes EE
    J Clin Oncol; 2015 Mar; 33(8):968. PubMed ID: 25667282
    [No Abstract]   [Full Text] [Related]  

  • 2. In regard to Suntharalingam et al. IJROBP 2000;47(1):49-56.
    Ochel H
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):281-2. PubMed ID: 11163527
    [No Abstract]   [Full Text] [Related]  

  • 3. The never-ending story: finding a role for neoadjuvant chemotherapy in the management of head and neck cancer.
    Garden AS
    J Clin Oncol; 2014 Sep; 32(25):2685-6. PubMed ID: 25049324
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary: bevacizumab and erlotinib with chemoradiation for head and neck cancer.
    Burtness B
    Cancer J; 2011; 17(5):273-5. PubMed ID: 21952274
    [No Abstract]   [Full Text] [Related]  

  • 5. Does DeCIDE give a decisive answer against induction chemotherapy in head and neck cancers?
    Chakraborty S; Patil VM
    J Clin Oncol; 2015 Mar; 33(8):967. PubMed ID: 25667296
    [No Abstract]   [Full Text] [Related]  

  • 6. Looking beyond the CRT paradigm: why induction chemotherapy is worthy of pursuit.
    Adkins D; Ley J; Michel L; Wildes TM; Thorstad W; Rich J; Nussenbaum B
    Oral Oncol; 2015 Feb; 51(2):103-4. PubMed ID: 25497105
    [No Abstract]   [Full Text] [Related]  

  • 7. A new look at induction chemotherapy in locally advanced head and neck cancer.
    Vermorken JB
    Oncologist; 2010; 15 Suppl 3():1-2. PubMed ID: 21036881
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant chemotherapy for resectable squamous cell carcinoma of the head and neck. Report on Intergroup Study 0034.
    Hong WK
    Int J Radiat Oncol Biol Phys; 1992; 23(4):885-6. PubMed ID: 1618679
    [No Abstract]   [Full Text] [Related]  

  • 9. Is induction chemotherapy the new standard in organ preservation treatment for locally advanced head and neck cancer in 2010?
    Porceddu SV
    Asia Pac J Clin Oncol; 2010 Jun; 6(2):75-6. PubMed ID: 20565417
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy in head and neck cancer.
    Armand JP; Couteau C
    Eur J Cancer; 1995; 31A(5):819-22. PubMed ID: 7640066
    [No Abstract]   [Full Text] [Related]  

  • 11. Integrating novel agents into the curative treatment of head and neck cancer.
    Haddad R; Allen A; Wirth L; Tishler R; Posner M
    Expert Rev Anticancer Ther; 2006 Feb; 6(2):157-9. PubMed ID: 16445367
    [No Abstract]   [Full Text] [Related]  

  • 12. [Head and neck: molecular-targeted therapy].
    Tsukuda M
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1034-9. PubMed ID: 17682304
    [No Abstract]   [Full Text] [Related]  

  • 13. [Multimodal treatment of inoperable oral and maxillofacial squamous cell carcinoma].
    Platz H; Engleder R; Fridrik M; Hudec M; Schwarzl G
    Z Stomatol; 1988 Oct; 85(6):359-70. PubMed ID: 3274597
    [No Abstract]   [Full Text] [Related]  

  • 14. Future directions in the chemotherapy of head and neck cancer.
    Grunberg SM
    Am J Clin Oncol; 1985 Feb; 8(1):51-4. PubMed ID: 2581435
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of chemotherapy in the treatment of head and neck cancer.
    Inuyama Y; Fukuda S; Furuta Y; Yagi K; Nagahashi T; Chida E; Shirato H; Fujii M; Kanzaki J
    Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():52-9. PubMed ID: 9210888
    [No Abstract]   [Full Text] [Related]  

  • 16. [A combination of radiotherapy and chemotherapy with platidiam and fluorouracil in patients with head and neck cancer].
    Shparyk IaV; Kravets AI; Bilyns'kyĭ BT; Kuftiak OF
    Lik Sprava; 1996; (3-4):153-7. PubMed ID: 9035857
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of cis-platinum and 5-fluorouracil as induction chemotherapy prior to radiation therapy in advanced head and neck cancer.
    Thongprasert S; Lorvidhaya V; Sumitsawan Y; Tonusin A; Phandphae P; Changwaiwit W; Chaimongkol B
    J Med Assoc Thai; 1988 Nov; 71(11):602-4. PubMed ID: 3221145
    [No Abstract]   [Full Text] [Related]  

  • 18. [The viewpoint of the radiotherapy oncologist].
    Corvò R
    Tumori; 2008; 94(4):suppl 30-3. PubMed ID: 18822715
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck cancer.
    Ohashi T; Ohnishi M; Tanahashi S; Murai M
    Jpn J Clin Oncol; 2011 Mar; 41(3):348-52. PubMed ID: 21109512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous chemoradiation for squamous carcinomas.
    Tobias JS; Ball D
    BMJ; 2001 Apr; 322(7291):876-8. PubMed ID: 11302885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.